{"date":"2025-02-08","count":3,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7724-2025-02-08-2355-1po3jp7","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-02-08","time":"23:55:29","subject":"公告本公司財務長取消到職","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-02-08 23:55，「公告本公司財務長取消到職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-02-08-2242-1nffv2","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-02-08","time":"22:42:44","subject":"公告本公司回應民國114年2月7日媒體報導之聲明","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-02-08 22:42，「公告本公司回應民國114年2月7日媒體報導之聲明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-02-08-1608-19fl4nl","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-02-08","time":"16:08:06","subject":"代子公司歐帕生技醫藥股份有限公司法人董事代表人異動暨三分之一以上董事發生變動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-02-08 16:08，「代子公司歐帕生技醫藥股份有限公司法人董事代表人異動暨三分之一以上董事發生變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}